NOOTROPIL IN TREATMENT OF DISORDERS OF HI GH MENTAL FUNCTIONS IN PATIENTS WITH ISCHEMIC STROKE

47 patients with acute ischemic stroke were treated with nootropil (py racetam, UCB, Belgium) from the first day of the disease (12 g, intrav enously, by drops during 2 weeks, then 4.8 g, per os) on the backgroun d of basic therapy. There was revealed increase of spontaneus activity , expressive and impulsive speech, audio-and speaking memory (especial ly delayed memory), tactile, acustic and visual gnosis, space praxis. There was observed more pronounced positive dynamics of functions of d amaged hemisphere in patients with localisation of ischemic focus in l eft hemisphere. Meanwhile restoration was slower when ischemic focus w as localized in right hemisphere, Restoration of high mental functions occured to be faster during nootropil treatment as compared with basi c therapy only. The conclusion was made that nootropil can be prescrip ted for the patients with hemispheric ischemic stroke and especially f or the patients with alterations of cerebral circulation in system of internal carotid artery including such disturbances on the background of insufficiency of circulation in vertebrobasilar system.